Copyright
©The Author(s) 2017.
World J Gastrointest Pathophysiol. Aug 15, 2017; 8(3): 108-116
Published online Aug 15, 2017. doi: 10.4291/wjgp.v8.i3.108
Published online Aug 15, 2017. doi: 10.4291/wjgp.v8.i3.108
Table 3 Current evidence of liver transplantation in sickle cell disease
Author | Number of patients | Outcomes |
Hurtova et al[46] | 6 | 1, 3, 5, and 10-yr survival rates were 83.3%, 66.7%, 44.4%, and 44.4%, respectively |
Mekeel et al[48] | 3 | Patient and graft survival was 66% |
Baichi et al[49] | 2 | 100% mortality in post-transplant period due to multiorgan failure |
Emre et al[50] | 1 | Failure of graft in 5 mo due to SCD crisis |
Greenberg et al[51] | 1 | Successful but follow up only till day 28 |
Kindscher et al[52] | 1 | Successful with extrahepatic complications |
Lang et al[53] | 1 | Successful at 6 mo |
Ross et al[54] | 1 | Successful at 22 mo - death due to PE |
van den Hazel et al[55] | 1 | Successful at 5.5 yr |
Gilli et al[56] | 1 | Successful at 2 yr |
Berry[57] | 1 | Death in post-op period |
- Citation: Shah R, Taborda C, Chawla S. Acute and chronic hepatobiliary manifestations of sickle cell disease: A review. World J Gastrointest Pathophysiol 2017; 8(3): 108-116
- URL: https://www.wjgnet.com/2150-5330/full/v8/i3/108.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v8.i3.108